Ambea AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009663826
SEK
131.50
-0.5 (-0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ambea AB stock-summary
stock-summary
Ambea AB
Pharmaceuticals & Biotechnology
Ambea AB (publ) is a Sweden-based holding company within the care provider group. The Ambea group offers accommodation, support, training and staffing within health and social care. The Group has over 450 units throughout Sweden and in Norway. The Swedish operations comprise the brands Vardaga, Lara and Bemanning. Among other brands, there are Rent a Doctor, Rent a Nurse, Rent a Socionom and Careteam, as well as BoA Mellanvard. The Norwegian operations comprise support and residential care in disabilities and psychiatry through the companies Heimta and Vitale. The Company’s main shareholders are ACTR Holding Ab and Actor General Partner SARL Sweden SCA. It operates Malrettet Intervensjon AS, Elevhalsan, Stod och Resurs AB and Tiltaksgruppa fokus as subsidiaries.
Company Coordinates stock-summary
Company Details
Evenemangsgatan 21, 6 tr, Box 1565 , SOLNA None : 171 29
stock-summary
Tel: 46 8 5787000046 495 40752
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Lena Andersson Hofsberger
Independent Chairman of the Board
Mr. Daniel Bjorklund
Director
Mr. Anders Borg
Director
Ms. Patricia Briceno Rodriguez
Director, Employee Representative for Kommunal
Mr. Haralampos Kalpakas
Director, Employee Representative for the Swedish Association of Health Professionals
Mr. Magnus Sallstrom
Director, Employee Representative of Vision
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
4,088 Million
(Quarterly Results - Jun 2025)
Net Profit:
95 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 10,748 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

122.22%

stock-summary
Debt Equity

0.88

stock-summary
Return on Equity

13.52%

stock-summary
Price to Book

2.01